1. X
  2. Jarushka Naidoo
Log inSign up
Jarushka Naidoo
6,246 posts
Image
user avatar
Jarushka Naidoo
@DrJNaidoo
Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune Toxicity | Adjunct faculty Johns Hopkins University
scholar.google.com/citations?user…
Joined March 2018
1,101
Following
11.8K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Dec 15, 2022
    It’s official 🎓🎉 Pleased to announce my new role as Academic Professor @CancerCentreIre @RCSI_Irl @Beaumont_Dublin Thanks to the village of mentors, collaborators & supporters #ASCOLDP22 @ASCO @myESMO @MSKCancerCenter @etop_ibcsg @HopkinsThoracic @JulieBrahmer @DrLizJaffee
    user avatar
    RCSI
    @RCSI_Irl
    Dec 15, 2022
    Prof Jarushka Naidoo @DrJNaidoo has been appointed RCSI Professor of Medical Oncology. She will lead RCSI’s innovative medical #CancerResearch team to further its growth and continue its work to translate research findings into treatments. rcsi.com/dublin/news-an… #RCSIdiscover
    Image
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Sep 22, 2020
    An announcement: excited to be back home in Dublin, starting a new position at Beaumont Hospital Dublin & leading the lung cancer group in @cancertrials_ie. Looking forward to the next chapter! @Beaumont_Dublin @RCSI_Irl collaborations continue with my @HopkinsThoracic family
    Image
    Image
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Oct 6, 2024
    Superb article on the secret sauce of team science, in @NatureBiotech: It takes two to think ‘Morale thrives on the encouragement we get from the feedback of someone who understands our work & it’s motivations’ Great read nature.com/articles/s4158…
    Image
    42K042K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Jan 30, 2022
    Larotrectinib in NTRK Fusion+ NSCLC: - 20 nsclc pts from 3 early ph trials - ORR 73% (1 CR, 10 PRs) - mDOR 33.9mo; PFS 35.4mo; mOS 40.7mo NTRK may be a needle in a haystack, but if u find it- it’s a golden needle 🙏🏼 ⁦@OncoAlert⁩ #LCSM
    Image
    ascopubs.org
    Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive...
    PURPOSELarotrectinib is a highly selective and CNS-active tropomyosin receptor kinase (TRK) inhibitor that has demonstrated efficacy across TRK fusion–positive cancers, regardless of the tumor type....
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Apr 5, 2024
    🔥Big News Press Release: Ph III ADRIATIC Trial meets OS & PFS Endpoints for Durva v Placebo in Limited Stage SCLC: - 730pts with LS-SCLC post cCRT - pts randomised to Durva +/- Treme post cCRT v pbo Can't wait to see the full data @OncoAlert #LCSM astrazeneca.com/media-centre/p…
    Image
    24K024K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Sep 16, 2024
    #ESMO24 Lung mini-orals🔥 Randomised ph II trial of inhaled corticosteroids in stage III NSCLC treated with cCRT, to reduce radiation pneumonitis: - 292pts - 15% reduction in RP - no long-term steroid tox No need for ph III, could do tomorrow #ESMOAmbassadors #ESMO24 @myESMO
    Image
    Image
    Image
    16K016K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Mar 21, 2021
    José Baselga was physician-in-chief @sloan_kettering when I was a fellow. I remember he used to say, keep a list of your 5 career goals in your top drawer. ‘Everytime anyone asks u to do something, open the drawer. If it doesn’t fit- say no- if it fits, go’ RIP to a mentor& icon
    user avatar
    OncoAlert
    @OncoAlert
    Mar 21, 2021
    Prof. José Baselga has passed on March 21st Dr.Baselga was an amazing oncologist& researcher who paved the way for many molecular targeted therapies in2017 was awarded the @myESMO Lifetime Achievement Award Huge loss for the Oncology Community Our thoughts are with his family
    Image
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Nov 18, 2024
    'TrialGPT:' A new chatGPT for clinical trials @Nature - 3 steps: TrialGPT-Retrieval, TrialGPT-Matching, TrialGPT-Ranking - Retrieval identified 90% of suitable trials - 42% time-saving in matching a patient to a trial Like, wow @OncoAlert #LCSM
    Content cover image
    Matching patients to clinical trials with large language models
    From nature.com
    23K023K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Oct 30, 2024
    Introducing the Beaumont RCSI ICS Lung Cancer program grant, a €4.9mil investment from @IrishCancerSoc for: - Ireland’s first early detection pilot - Liquid biopsy research - Primary care research - Investigator-led KRAS/IO trials Delighted PI @myESMO @IASLC @CancerCentreIre
    Image
    Image
    user avatar
    RTÉ News
    @rtenews
    Oct 30, 2024
    A €4.9m lung cancer research programme funded by the Irish Cancer Society has been launched. The society said the programme marks its biggest single investment in the area of lung cancer rte.ie/news/health/20…
    26K026K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Jan 2, 2022
    Love this beautifully clear method on how to write a scientific paper #MedTwitter @OncoAlert
    user avatar
    Andrew M. Ibrahim MD, MSc
    @AndrewMIbrahim
    Aug 13, 2021
    Replying to @elliotthaut @juliomayol and 5 others
    How to write a scientific paper in four slides. Full guide here: surgeryredesign.com/s/WritingForIm… Lecture format here: m.youtube.com/watch?v=4P7flD…
    Image
    Image
    Image
    Image
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    May 4, 2022
    Excited to be ⁦@ASCO⁩ headquarters today for #ASCOLDP21 🇺🇸🇮🇪 ⁦@hemoncwarner⁩ ⁦@MGZauderer⁩ ⁦@maryam_lustberg⁩ ⁦@rachnatshroff⁩ ⁦@ErikaHamilton9⁩ ⁦@cancerassassin1⁩ ⁦@KlempnerSam⁩ ⁦@joan_schiller⁩ ⁦@tomleblancMD⁩ &more
    Image
    Image
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Mar 15, 2024
    An honor to present to the US congressional cancer caucus on US-Ireland cancer research collaboration 🇺🇸🇮🇪 >50% of Irish oncologists are US-trained, & many now leaders in the field We propose to grow these links with strategic investment, & in areas of need such as lung cancer
    Image
    Image
    Image
    Image
    14K014K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Sep 3, 2023
    It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’ Both The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness Great paper @ESMO_Open @DrJonLim
    Image
    Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
    From esmoopen.com
    20K020K
  • user avatar
    Jarushka Naidoo
    @DrJNaidoo
    Mar 29, 2025
    My #ELCC25 Top 3: 1. #MARIPOSA: meets OS (HR 0.75), but tox burden limits to a subset of pts? Controversial 2. #KRYSTAL7: mPFS 27.7m. Way better than I expected. One to watch 3. #Deescalation trials by @BenjaminBesseMD. Let’s be good oncologists, &good citizens Thanks @myESMO
    Image
    Image
    Image
    11K011K
Advertisement
Advertisement